Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
“These results suggest that taurine offers a protective effect against CP-induced urinary bladder damage… Moringa leaves play an important role in ameliorating and protecting the bladder from
Continue readingHyperbaric Oxygen Therapy Stimulates Stem Cells, Heals Radiation Damage and may even Kill Cancer HBOT is an ideal multiple myeloma therapy for the newly diagnosed MM survivor about to undergo an ASCT and
Continue reading“Acute haemorrhagic cystitis occurs in 30 per cent of patients receiving high dose cyclophosphmide . The case highlights that late and severe haemorrhagic cystitis can develop even when cyclophasphamide
Continue readingWhole-Body Hyperthermia (sauna) is cytotoxic to myeloma, lowers blood pressure, rids the body of heavy metals and is relaxing… Whole-Body Hyperthermia (sauna) is about as non-conventional a multiple
Continue readingI am a long-term survivor of Multiple Myeloma, an incurable blood cancer. From the tine of my diagnosis in early 1994 until my oncologist told me “there is nothing more we can do for you, “
Continue reading“…among the lenalidomide-treated patients, grade 3 or 4 hematologic and nonhematologic adverse events occurred in 36 patients (41%), with nonhematologic adverse events occurring in 25 patients
Continue readingMultiple Myeloma (MM) remission criteria can indicate the mm survivor’s prognosis. Let me explain- Remission… what does this mean? Should you attempt to reach minimal residual disease (MDR)
Continue reading“Gadolinium (Gd)-based contrast agents are frequently used to enhance MRI resolution. We evaluated effect of the most common Gd-containing agent, Omniscan, on myeloma cells.” Multiple myeloma
Continue reading“Toxicity (for elderly Multiple Myeloma patients) is a significant concern, and doses of thalidomide and of myelotoxic agents should be reduced in patients who are older than 75 years or who have
Continue readingThis real-life survey indicates that re-treatment including bortezomib as a first salvage therapy could be still considered in MM patients achieving durable response after initial exposure to bortezomib
Continue readingOverall, a substantial risk of VTE associated with lenalidomide-based regimens (MM side effect) was evident in controlled clinical trial settings, despite adequate thromboprophylaxis.” You’ve
Continue reading“What determines the risk of progression from asymptomatic to symptomatic myeloma…Most widespread and validated adversely predictive chromosomal aberrations (high-risk aberrations) in this
Continue reading